Recent breakthroughs in understanding the prostaglandin D2 (PGD2) receptor 1 (DP1) are paving the way for innovative ...

Compounded medications are custom-made formulations designed to meet specific patient needs when commercial drugs are ...

(1) Assumes $3 - $5 million COLI earnings. (2) Net income and rate base compound annual growth rate: base year 2025. In a separate press release issued today, Centuri Holdings affirmed its ...

Here, the authors design a 1’(one)-psoralen-conjugated triplex-forming oligonucleotide to achieve stable parallel triplex formation and photo-cross-linking formation with pyrimidine-base ...

Here, the authors design a 1’(one)-psoralen-conjugated triplex-forming oligonucleotide to achieve stable parallel triplex formation and photo-cross-linking formation with pyrimidine-base ...

This study represents the first example an environmentally benign, sustainable, and practical synthesis of substituted quinolines and pyrimidines using combinations of 2-aminobenzyl alcohols and ...

Giza recently raised $5.2 million from CoinFund, Arrington Capital and Base Ecosystem Fund ... with protocols such as AAVE, Morpho, and Compound. This will allow Giza’s AI agents to ...

Contribution from the IWR-Computational Molecular Biophysics, Universität Heidelberg, Im Neuenheimer Feld 368, D-69120 Heidelberg, Germany, and Physikalisch-Chemisches Institut, Universität Heidelberg ...

The USAN program assigns a USANM to a substance when another form of it has already received a USAN. If the parent substance does not have a USAN, the sponsor must apply for a new USAN. A fee of ...